drugset / Trial / NCT00506701
Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension
Withdrawn
Herlev Hospital
NaSingle-groupTriple-blindTreatment
Summary
Tadalafil may lower the pulmonary artery pressure in patients with Chronic Obstructive Lung Disease and secondary pulmonary hypertension and thereby improve patients quality of life.
Timeline
- Start
- 2008-02
- Primary completion
- 2010-02
- Completion
- 2010-02
Outcome
Outcome not reported
Stopped (Business): “due to lack of finance”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tadalafil | Small molecule | 40 mg | — |